Spring Symposium Agenda - Hollings Cancer Center

The laboratory component of his research develops new biomarkers of cancer risk related to diet and lifestyle, while his epidemiological component accrues special populations. At OSU, he is co-PI
of a multi-institutional clinical trial for tobacco products, and is
continuing his research on breast and lung cancer.
You are invited to the Hollings Cancer Center
2014 Spring Research Symposium
Isaac J. Powell, MD is Professor, Department of Urology Wayne State University and Karmanos Cancer Institute. The focus of my research is on the many ways
prostate cancer impacts African Americans in comparison to other ethnic groups. Past research has included a community-based education, health care behavior modification and early detection study of prostate cancer among African
American men. We are also studying environmental and life style
factors such as diet and inflammation in correlation to clinical
outcome and how they impact on genes. He was recently funded
to examine Metabolic Syndrome and Prostate Cancer. Dr. Powell
is part of an International Consortium Prostate Cancer Genetics
(ICPCG) group and we are comparing hereditary prostate cancer
genetic results among African American men in comparison to
other ethnicities with other centers around the world. He received
his MD degree from the Indiana University Medical School.
“Translating
Cancer Control Science
into Practice”
Timothy Rebbeck, PhD is Professor of Epidemiology, Director of the Center for Genetics and Complex
Traits, Director of the Center of Excellence in Prostate
Cancer Disparities, and Associate Director for Population Science in the Abramson Cancer Center at the
University of Pennsylvania. He is the Editor-in-Chief of the journal
Cancer Epidemiology, Biomarkers, and Prevention. The goal of Dr.
Rebbeck’s research is to understand the complex, multifactorial
etiology of cancer and cancer disparities. Dr. Rebbeck’s research
focuses on cancers of the breast, ovary, and prostate, with an emphasis on global health disparities. Dr. Rebbeck received the 2011
Landon Award for International Research for the development of
this consortium and its research, and was named a Fulbright Specialist to develop cancer research centers of excellence in Africa in
2011. He received his PhD from the University of Michigan.
Friday, March 14, 2014 • 8:00 AM – 3:30 PM
Daniel Island Club
600 Island Park Drive
Daniel Island, SC
For details and for registration, please visit
http://hcc.musc.edu/research/conferences/index.htm
Registration deadline: March 7, 2014
Hollings Cancer Center • 2014 Spring Research Symposium
“Translating Cancer Control
Science into Practice”
AGENDA
Friday, March 14, 2014
8:00 am Registration and Breakfast
8:30 am Welcome
Andrew Kraft, MD
8:35 am “Setting the Stage: The Epidemiology of Cancer in
South Carolina”
Anthony Alberg, PhD, MPH
8:50 am “Enhancing dissemination through marketing and
distribution systems: A vision for cancer control”
Matthew Kreuter, PhD, MPH
9:25 am “A multi-level approach to integrating patient
navigation into the healthcare system”
Elizabeth Calhoun, PhD
0:00 am Break
1
10:15 am “Biomarkers, ‘Omics and Breast Cancer”
Peter Shields, MD
10:45 am “Understanding the Clinical, Biologic, and Behavioral
Effects of Tobacco to Improve Clinical Cancer Care
and Research”
Graham Warren, MD, PhD
11:20 am Lunch and Networking
1:00 pm “Reducing Lung Cancer Mortality by 50% in the Next
Decade - Translating Science into Practice”
Michael Cummings, PhD, MPH
1:30 pm “Clinical and Molecular Biology of Prostate Cancer
among African Americans Compared to European
Americans”
Isaac Powell, MD
2:05 pm Break
2:20 pm “Vitamin D and Prostate Cancer”
Sebastiano Gattoni-Celli, MD
2:40 pm “Prostate Cancer Disparities: From Nucleotide to
Neighborhood”
Timothy Rebbeck, PhD
3:15 pm Closing Remarks
Chanita Hughes-Halbert, PhD
External Symposium Faculty
Matthew W. Kreuter, PhD, MPH is Professor and Associate Dean for Public Health at The Brown School at
Washington University in St. Louis. He is founder of
the Brown School’s Health Communication Research
Laboratory (HCRL), one of five national Centers of Excellence in Cancer Communication Research as designated by the
National Cancer Institute. He directed the HCRL for 17 years and
now serves as its Senior Scientist. His research explores strategies
to increase the reach and effectiveness of health information and
connections to health services in low-income and minority populations to help eliminate health disparities. Dr. Kreuter is a member
of the Institute of Medicine Board on Population Health and Public
Health Practice. He received his PhD and MPH in Health Behavior
and Health Education from the School of Public Health at the University of North Carolina – Chapel Hill.
Elizabeth Calhoun, PhD is Professor in the Division
of Health Policy and Administration of the UIC School
of Public Health. She is currently the Director of the
Center of Excellence in Eliminating Disparities (CEED)
funded by NIMHD and the Co-Director for UIC Center
for Population Health and Health Disparities funded by NCI. She
is a member of the Executive Committee of the National Patient
Navigator Consortium, advocating for patient navigators integration into the health system. Most recently, she received funding to
lead the Illinois Navigators Training Program for the training of
Navigators, In-Person Counselors and Certified Application Counselors for implementation of the Affordable Care Act across the
state of Illinois.
Peter Shields, MD is currently a tenured professor in
the Division of Cancer Prevention and Control and
Deputy Director of The Ohio State University Comprehensive Cancer Center. He moved from Georgetown
University in 2011, where he was the Deputy Director
of the Lombardi Comprehensive Cancer Center, past Interim-Chair
of the Department of Medicine, Vice-Chair of the Department of
Oncology, Associate Director for Cancer Control and Population
Sciences, and Program Leader for Cancer Genetics and Epidemiology in the Cancer Center. Dr. Shields’ focus of research is on
gene-environment interactions for breast and lung cancer risk.
continued on back